S100A4 in cancer progression and metastasis: A systematic review

被引：153

作者：

Fei, Fei ^{[1
,2
]}

Qu, Jie ^{[1
,2
]}

Zhang, Mingqing ^{[3
]}

Li, Yuwei ^{[3
]}

Zhang, Shiwu ^{[2
]}

机构：

[1] Nankai Univ, Nankai Univ Sch Med, Tianjin 300071, Peoples R China

[2] Tianjin Union Med Ctr, Dept Pathol, Tianjin 300121, Peoples R China

[3] Tianjin Union Med Ctr, Dept Colorectal Surg, Tianjin 300121, Peoples R China

来源：

ONCOTARGET | 2017年 / 8卷 / 42期

基金：

美国国家科学基金会;

关键词：

S100A4; metastasis; malignant tumor; epithelial-mesenchymal transition; CALCIUM-BINDING PROTEIN; CELLS IN-VITRO; EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN COLORECTAL-CANCER; E-CADHERIN EXPRESSION; PROGNOSTIC-SIGNIFICANCE; MESSENGER-RNA; GENE-EXPRESSION; DOWN-REGULATION; HEPATOCELLULAR-CARCINOMA;

D O I：

10.18632/oncotarget.18016

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Metastasis is the leading cause of cancer-related death and directly associates with cancer progression, resistance to anticancer therapy, and poor patient survival. Current efforts focusing on the underlying molecular mechanisms of cancer metastasis attract a special attention to cancer researchers. The epithelial-mesenchymal transition is a complex of molecular program during embryogenesis, inflammation, tissue fibrosis, and cancer progression and metastasis. S100A4, an important member of S100 family proteins, functions to increase the tumor progression and metastasis. The molecular mechanisms of S100A4 involving in the progression and metastasis are diverse in various malignant tumors. Detection of S100A4 expression becomes a promising candidate biomarker in cancer early diagnosis and prediction of cancer metastasis and therefore, S100A4 may be a therapeutic target. This review summarized up to date advancement on the role of S100A4 in human cancer development, progression, and metastasis and the underlying molecular events and then strategies to target S100A4 expression experimentally.

引用

页码：73219 / 73239

页数：21

共 193 条

[21] Osteopontin-an important downstream effector of S100A4-mediated invasion and metastasis [J].

Berge, Gisle ;

Pettersen, Solveig ;

Grotterod, Ida ;

Bettum, Ingrid J. ;

Boye, Kjetil ;

Maelandsmo, Gunhild M. .

INTERNATIONAL JOURNAL OF CANCER, 2011, 129 (04) :780-790

[22] Metabolic reprogramming supports the invasive phenotype in malignant melanoma [J].

Bettum, Ingrid J. ;

Gorad, Saurabh S. ;

Barkovskaya, Anna ;

Pettersen, Solveig ;

Moestue, Slyer A. ;

Vasiliauskaite, Kotryna ;

Tenstad, Ellen ;

Oyjord, Tove ;

Risa, Oystein ;

Nygaard, Vigdis ;

Maelandsmo, Gunhild M. ;

Prasmickaite, Lina .

CANCER LETTERS, 2015, 366 (01) :71-83

[23] Metastasis-associated protein S100A4 induces a network of inflammatory cytokines that activate stromal cells to acquire pro-tumorigenic properties [J].

Bettum, Ingrid J. ;

Vasiliauskaite, Kotryna ;

Nygaard, Vigdis ;

Clancy, Trevor ;

Pettersen, Solveig J. ;

Tenstad, Ellen ;

Maelandsmo, Gunhild M. ;

Prasmickaite, Lina .

CANCER LETTERS, 2014, 344 (01) :28-39

[24] Structure of the Ca2+/S100B/NDR kinase peptide complex:: Insights into S100 target specificity and activation of the kinase [J].

Bhattacharya, S ;

Large, E ;

Heizmann, CW ;

Hemmings, B ;

Chazin, WJ .

BIOCHEMISTRY, 2003, 42 (49) :14416-14426

[25]

Bjornland K, 1999, CANCER RES, V59, P4702

[26] Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment [J].

Blechacz, Boris ;

Gores, Gregory J. .

HEPATOLOGY, 2008, 48 (01) :308-321

[27] Recent advances in osteosarcoma [J].

Botter, Sander M. ;

Neri, Dario ;

Fuchs, Bruno .

CURRENT OPINION IN PHARMACOLOGY, 2014, 16 :15-23

[28] Sulfiredoxin Redox-Sensitive Interaction with S100A4 and Non-Muscle Myosin IIA Regulates Cancer Cell Motility [J].

Bowers, Robert R. ;

Manevich, Yefim ;

Townsend, Danyelle M. ;

Tew, Kenneth D. .

BIOCHEMISTRY, 2012, 51 (39) :7740-7754

[29] Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapy [J].

Boye, Kjetil ;

Jacob, Havjin ;

Frikstad, Kari-Anne M. ;

Nesland, Jahn M. ;

Maelandsmo, Gunhild M. ;

Dahl, Olav ;

Nesbakken, Arild ;

Flatmark, Kjersti .

CANCER MEDICINE, 2016, 5 (08) :1840-1849

[30] Nuclear S100A4 is a novel prognostic marker in colorectal cancer [J].

Boye, Kjetil ;

Nesland, Jahn M. ;

Sandstad, Berit ;

Moelandsmo, Gunhild M. ;

Flatmark, Kjersti .

EUROPEAN JOURNAL OF CANCER, 2010, 46 (16) :2919-2925

← 1 2 3 4 5 6 7 8 9 10 →